获得癌症查服务的评估指标:范围审查
1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Public health
|August 17, 2024
概括
这项研究审查了331篇关于癌症查准入的出版物,确定了关键指标. 这些发现将有助于开发一个更好的系统来评估癌症查的准入和可用性.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 癌症流行病学 癌症流行病学
- 公共卫生 公共卫生
背景情况:
- 获得医疗保健服务,特别是癌症查,对于有效的公共卫生战略至关重要.
- 国际癌症研究机构 (IARC) 强调"可用性"是癌症查的关键指标.
- 目前评估和报告癌症查准入指标的方法不一致,阻碍了基于证据的决策.
研究的目的:
- 系统地识别和整理用于评估获得癌症查服务的现有指标.
- 了解这些指标的当前应用和使用中的差距.
- 为制定癌症查准入标准化评估系统提供信息.
主要方法:
- 对2013年至2022年间发表的研究进行了全面的范围审查.
- 获取和量化了获得癌症查服务的指标.
- 提取的指标被映射到两个既定框架:医疗保健获得的普遍五维框架 (U5D) 和IARC的癌症特定框架.
主要成果:
- 总共有331项研究被纳入了审查.
- 分析揭示了各种各样的指标,包括供给侧 (例如,可靠性,可用性) 和需求侧 (例如,感知,寻找,接触,支付的能力) 的观点.
- 还确定了IARC认可的与政策,查类型,覆盖范围和人口统计相关的指标,从而提出了一个综合框架.
结论:
- 这次审查成功地确定并组织了一系列评估癌症查准入的指标.
- 确定了这些指标当前应用中的重大差距.
- 这些发现为开发一个强大而系统的指标系统提供了基础,以改善癌症查评估和可访问性.
相关概念视频
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
01:30Preventive Healthcare Services
977
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
977
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:25Statistical Methods for Analyzing Epidemiological Data
336
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
336
01:20Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
01:12Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103